Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants

Costantino Romagnoli; Giovanni Vento

doi:10.1542/peds.2013-0007

Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants

Costantino Romagnoli, Giovanni Vento

Risultato della ricerca: Contributo in rivista › Articolo in rivista

10 Citazioni (Scopus)

Abstract

The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitric oxide (iNO) compared with placebo in infants with respiratory failure. This follow-up study evaluated respiratory, neurodevelopmental, and other outcomes for infants entered into the European Union Nitric Oxide trial to age 2 years.

Lingua originale	English
pagine (da-a)	e695-e703
Rivista	Pediatrics
Volume	132
DOI	https://doi.org/10.1542/peds.2013-0007
Stato di pubblicazione	Pubblicato - 2013

Keywords

Administration, Inhalation
Bronchodilator Agents
Child, Preschool
European Union
Female
Follow-Up Studies
Humans
Infant
Infant, Newborn
Male
Nitric Oxide
Respiratory Distress Syndrome, Newborn
Survival Rate
developmental outcomes
growth
inhaled nitric oxide
premature infants
randomized controlled trial

Accesso al documento

10.1542/peds.2013-0007

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{977bda44a916402f91ca1471a173e610,

title = "Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants",

abstract = "The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitric oxide (iNO) compared with placebo in infants with respiratory failure. This follow-up study evaluated respiratory, neurodevelopmental, and other outcomes for infants entered into the European Union Nitric Oxide trial to age 2 years.",

keywords = "Administration, Inhalation, Bronchodilator Agents, Child, Preschool, European Union, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Nitric Oxide, Respiratory Distress Syndrome, Newborn, Survival Rate, developmental outcomes, growth, inhaled nitric oxide, premature infants, randomized controlled trial, Administration, Inhalation, Bronchodilator Agents, Child, Preschool, European Union, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Nitric Oxide, Respiratory Distress Syndrome, Newborn, Survival Rate, developmental outcomes, growth, inhaled nitric oxide, premature infants, randomized controlled trial",

author = "Costantino Romagnoli and Giovanni Vento",

year = "2013",

doi = "10.1542/peds.2013-0007",

language = "English",

volume = "132",

pages = "e695--e703",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

}

TY - JOUR

T1 - Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants

AU - Romagnoli, Costantino

AU - Vento, Giovanni

PY - 2013

Y1 - 2013

N2 - The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitric oxide (iNO) compared with placebo in infants with respiratory failure. This follow-up study evaluated respiratory, neurodevelopmental, and other outcomes for infants entered into the European Union Nitric Oxide trial to age 2 years.

AB - The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitric oxide (iNO) compared with placebo in infants with respiratory failure. This follow-up study evaluated respiratory, neurodevelopmental, and other outcomes for infants entered into the European Union Nitric Oxide trial to age 2 years.

KW - Administration, Inhalation

KW - Bronchodilator Agents

KW - Child, Preschool

KW - European Union

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Infant

KW - Infant, Newborn

KW - Male

KW - Nitric Oxide

KW - Respiratory Distress Syndrome, Newborn

KW - Survival Rate

KW - developmental outcomes

KW - growth

KW - inhaled nitric oxide

KW - premature infants

KW - randomized controlled trial

KW - Administration, Inhalation

KW - Bronchodilator Agents

KW - Child, Preschool

KW - European Union

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Infant

KW - Infant, Newborn

KW - Male

KW - Nitric Oxide

KW - Respiratory Distress Syndrome, Newborn

KW - Survival Rate

KW - developmental outcomes

KW - growth

KW - inhaled nitric oxide

KW - premature infants

KW - randomized controlled trial

UR - http://hdl.handle.net/10807/52388

U2 - 10.1542/peds.2013-0007

DO - 10.1542/peds.2013-0007

M3 - Article

SN - 0031-4005

VL - 132

SP - e695-e703

JO - Pediatrics

JF - Pediatrics

ER -

Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo